Figueiredo, C. P., & Lorenz, H. (2017). Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs. Annals of the rheumatic diseases, 76(2), . https://doi.org/10.1136/annrheumdis-2016-209297
Chicago Style (17th ed.) CitationFigueiredo, Camille P., and Hanns-Martin Lorenz. "Antimodified Protein Antibody Response Pattern Influences the Risk for Disease Relapse in Patients with Rheumatoid Arthritis Tapering Disease Modifying Antirheumatic Drugs." Annals of the Rheumatic Diseases 76, no. 2 (2017). https://doi.org/10.1136/annrheumdis-2016-209297.
MLA (9th ed.) CitationFigueiredo, Camille P., and Hanns-Martin Lorenz. "Antimodified Protein Antibody Response Pattern Influences the Risk for Disease Relapse in Patients with Rheumatoid Arthritis Tapering Disease Modifying Antirheumatic Drugs." Annals of the Rheumatic Diseases, vol. 76, no. 2, 2017, https://doi.org/10.1136/annrheumdis-2016-209297.